Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adrenergic signaling in cardiomyocytes 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
2 Adrenergic signaling in cardiomyocytes 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
3 Adrenergic signaling in cardiomyocytes 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
4 Adrenergic signaling in cardiomyocytes 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
5 Adrenergic signaling in cardiomyocytes 💬
2件: ADRB1, ADRB2 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
6 Adrenergic signaling in cardiomyocytes 💬
2件: ADRB1, ADRB2 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
7 Adrenergic signaling in cardiomyocytes 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
8 Adrenergic signaling in cardiomyocytes 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
9 AGE-RAGE signaling pathway in diabetic complications 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
10 AGE-RAGE signaling pathway in diabetic complications 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
11 Alcoholism 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
12 Alcoholism 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
13 Aldosterone synthesis and secretion 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
14 Aldosterone synthesis and secretion 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
15 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
16 Aldosterone synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
17 Aldosterone-regulated sodium reabsorption 💬
1件: NR3C2 💬 D01115 💬 Eplerenone 4件: 75, 113, 210, 215 💬
18 Alzheimer disease 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
19 Alzheimer disease 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
20 Amphetamine addiction 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
21 Amphetamine addiction 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
22 Amyotrophic lateral sclerosis 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
23 Amyotrophic lateral sclerosis 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
24 Apelin signaling pathway 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
25 Apelin signaling pathway 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
26 Calcium signaling pathway 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
27 Calcium signaling pathway 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
28 Calcium signaling pathway 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
29 Calcium signaling pathway 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
30 Calcium signaling pathway 💬
3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
31 Calcium signaling pathway 💬
3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
32 Calcium signaling pathway 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
33 Calcium signaling pathway 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
34 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
35 Calcium signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
36 Calcium signaling pathway 💬
4件: GRIN1, GRIN2A, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
37 Calcium signaling pathway 💬
4件: GRIN1, GRIN2A, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
38 cAMP signaling pathway 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
39 cAMP signaling pathway 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
40 cAMP signaling pathway 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
41 cAMP signaling pathway 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
42 cAMP signaling pathway 💬
2件: ADRB1, ADRB2 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
43 cAMP signaling pathway 💬
2件: ADRB1, ADRB2 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
44 cAMP signaling pathway 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
45 cAMP signaling pathway 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
46 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
47 cGMP-PKG signaling pathway 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
48 cGMP-PKG signaling pathway 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
49 cGMP-PKG signaling pathway 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
50 cGMP-PKG signaling pathway 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
51 cGMP-PKG signaling pathway 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
52 cGMP-PKG signaling pathway 💬
3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
53 cGMP-PKG signaling pathway 💬
3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
54 cGMP-PKG signaling pathway 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
55 cGMP-PKG signaling pathway 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
56 Chemical carcinogenesis - receptor activation 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
57 Chemical carcinogenesis - receptor activation 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
58 Chemical carcinogenesis - receptor activation 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
59 Chemical carcinogenesis - receptor activation 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
60 Chemical carcinogenesis - receptor activation 💬
3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
61 Chemical carcinogenesis - receptor activation 💬
3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
62 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
63 Circadian entrainment 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
64 Circadian entrainment 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
65 Circadian entrainment 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
66 Cocaine addiction 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
67 Cocaine addiction 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
68 Complement and coagulation cascades 💬
1件: PLG 💬 D01136 💬 Tranexamic acid 6件: 46, 70, 215, 227, 288, 299 💬
69 Coronavirus disease - COVID-19 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
70 Coronavirus disease - COVID-19 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
71 Cortisol synthesis and secretion 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
72 Cortisol synthesis and secretion 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
73 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
74 Cortisol synthesis and secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
75 Cushing syndrome 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
76 Cushing syndrome 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
77 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
78 Cushing syndrome 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
79 Diabetic cardiomyopathy 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
80 Diabetic cardiomyopathy 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
81 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
82 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
83 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
84 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
85 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
86 Dilated cardiomyopathy 💬
1件: ADRB1 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
87 Dopaminergic synapse 💬
2件: GRIN2A, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
88 Dopaminergic synapse 💬
2件: GRIN2A, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
89 Estrogen signaling pathway 💬
1件: OPRM1 💬 D00320 💬 Fentanyl 4件: 46, 70, 215, 231 💬
90 Estrogen signaling pathway 💬
1件: OPRM1 💬 D01399 💬 Fentanyl 4件: 46, 70, 215, 231 💬
91 Gap junction 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
92 Gap junction 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
93 Gap junction 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
94 Gap junction 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
95 Gap junction 💬
1件: ADRB1 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
96 Gap junction 💬
1件: ADRB1 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
97 Glutamatergic synapse 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
98 Glutamatergic synapse 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
99 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
100 GnRH secretion 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
101 Huntington disease 💬
2件: GRIN1, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
102 Huntington disease 💬
2件: GRIN1, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
103 Influenza A 💬
1件: PLG 💬 D01136 💬 Tranexamic acid 6件: 46, 70, 215, 227, 288, 299 💬
104 Long-term potentiation 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
105 Long-term potentiation 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
106 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D01303 💬 Flunarizine 4件: 58, 86, 149, 215 💬
107 MAPK signaling pathway 💬
3件: CACNA1G, CACNA1H, CACNA1I 💬 D07971 💬 Flunarizine 4件: 58, 86, 149, 215 💬
108 Morphine addiction 💬
1件: OPRM1 💬 D00320 💬 Fentanyl 4件: 46, 70, 215, 231 💬
109 Morphine addiction 💬
1件: OPRM1 💬 D01399 💬 Fentanyl 4件: 46, 70, 215, 231 💬
110 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D00514 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
111 Neuroactive ligand-receptor interaction 💬
3件: ADRA2A, ADRA2B, ADRA2C 💬 D01205 💬 Dexmedetomidine 13件:  2 ,  4 ,  6 , 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 💬
112 Neuroactive ligand-receptor interaction 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
113 Neuroactive ligand-receptor interaction 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
114 Neuroactive ligand-receptor interaction 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
115 Neuroactive ligand-receptor interaction 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
116 Neuroactive ligand-receptor interaction 💬
3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
117 Neuroactive ligand-receptor interaction 💬
3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
118 Neuroactive ligand-receptor interaction 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
119 Neuroactive ligand-receptor interaction 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
120 Neuroactive ligand-receptor interaction 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
121 Neuroactive ligand-receptor interaction 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
122 Neuroactive ligand-receptor interaction 💬
1件: OPRM1 💬 D00320 💬 Fentanyl 4件: 46, 70, 215, 231 💬
123 Neuroactive ligand-receptor interaction 💬
1件: OPRM1 💬 D01399 💬 Fentanyl 4件: 46, 70, 215, 231 💬
124 Neuroactive ligand-receptor interaction 💬
1件: PLG 💬 D01136 💬 Tranexamic acid 6件: 46, 70, 215, 227, 288, 299 💬
125 Nicotine addiction 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
126 Nicotine addiction 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
127 Pathways in cancer 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
128 Pathways in cancer 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
129 Pathways of neurodegeneration - multiple diseases 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
130 Pathways of neurodegeneration - multiple diseases 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
131 Phospholipase D signaling pathway 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
132 Phospholipase D signaling pathway 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
133 Prion disease 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
134 Prion disease 💬
5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
135 Rap1 signaling pathway 💬
3件: GRIN1, GRIN2A, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
136 Rap1 signaling pathway 💬
3件: GRIN1, GRIN2A, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
137 Ras signaling pathway 💬
3件: GRIN1, GRIN2A, GRIN2B 💬 D00711 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
138 Ras signaling pathway 💬
3件: GRIN1, GRIN2A, GRIN2B 💬 D08098 💬 Ketamine 8件:  2 ,  4 ,  6 , 13, 70, 113, 156, 215 💬
139 Regulation of lipolysis in adipocytes 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
140 Regulation of lipolysis in adipocytes 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
141 Regulation of lipolysis in adipocytes 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
142 Regulation of lipolysis in adipocytes 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
143 Regulation of lipolysis in adipocytes 💬
3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
144 Regulation of lipolysis in adipocytes 💬
3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
145 Renin secretion 💬
1件: ADRB1 💬 D00632 💬 Dobutamine 3件: 57, 58, 215 💬
146 Renin secretion 💬
1件: ADRB1 💬 D03879 💬 Dobutamine 3件: 57, 58, 215 💬
147 Renin secretion 💬
1件: ADRB1 💬 D03880 💬 Dobutamine 3件: 57, 58, 215 💬
148 Renin secretion 💬
1件: ADRB1 💬 D03881 💬 Dobutamine 3件: 57, 58, 215 💬
149 Renin secretion 💬
3件: ADRB1, ADRB2, ADRB3 💬 D00483 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
150 Renin secretion 💬
3件: ADRB1, ADRB2, ADRB3 💬 D08443 💬 Propranolol 7件:  6 , 158, 167, 215, 227, 278, 296 💬
151 Renin secretion 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
152 Renin secretion 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
153 Renin-angiotensin system 💬
1件: AGTR1 💬 D00357 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
154 Renin-angiotensin system 💬
1件: AGTR1 💬 D08146 💬 Losartan 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
155